Compare Crescentis Capit with Similar Stocks
Stock DNA
Non Banking Financial Company (NBFC)
INR 204 Cr (Micro Cap)
NA (Loss Making)
21
0.00%
0.00
-4.04%
2.51
Total Returns (Price + Dividend) 
Latest dividend: 1.0000 per share ex-dividend date: Sep-07-2011
Risk Adjusted Returns v/s 
Returns Beta
News

Crescentis Capital Ltd is Rated Strong Sell
Crescentis Capital Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 12 June 2026, providing investors with the most up-to-date view of the stock’s fundamentals, returns, and technical outlook.
Read full news article
Crescentis Capital Ltd Valuation Shifts Signal Elevated Risk for Investors
Crescentis Capital Ltd, a micro-cap player in the Non Banking Financial Company (NBFC) sector, has seen a marked deterioration in its valuation metrics, prompting a downgrade to a Strong Sell rating. The company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios have shifted into risky territory, reflecting growing investor concerns amid weak financial performance and negative returns relative to benchmarks.
Read full news articleAre Crescentis Capital Ltd latest results good or bad?
Crescentis Capital Ltd's latest quarterly results for March 2026 reveal significant operational challenges within its investment-driven business model. The company reported net sales of -₹7.44 crores, a stark reversal from the positive ₹3.72 crores in the previous quarter, indicating a dramatic sequential decline of 300.00%. This sharp downturn suggests substantial volatility in revenue generation, likely exacerbated by adverse market conditions impacting its investment portfolio. The profit after tax margin collapsed to 98.79%, while the operating profit before depreciation, interest, and tax (PBDIT) fell to negative ₹8.73 crores, marking a notable deterioration in financial performance. The net loss for the quarter was ₹7.35 crores, reflecting a 94.49% decline year-on-year, further highlighting the company's struggle to maintain profitability. Crescentis Capital's return on equity (ROE) has also seen a ...
Read full news article Announcements 
Unmodified Opinon
30-May-2026 | Source : BSEsubmission of Declaraion pursuant to Regulation 33(3)(d)
Announcement under Regulation 30 (LODR)-Newspaper Publication
30-May-2026 | Source : BSENewspaper Publication of Quarterly & Yearly Financial Results as on 31st March 2026
Announcement under Regulation 30 (LODR)-Meeting Updates
29-May-2026 | Source : BSERe-appointment of Mr. Subba Rao Veera Venkata Meka as the Managing Director and Mr. Bhavanam Ruthvik Reddy as Whole Time Director & CEO for a period of Five Years w.e.f 12-09-2026 subject to approval of Shareholders
Corporate Actions 
No Upcoming Board Meetings
Crescentis Capital Ltd has declared 10% dividend, ex-date: 07 Sep 11
No Splits history available
No Bonus history available
Crescentis Capital Ltd has announced 7:10 rights issue, ex-date: 06 Jun 25
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Dr. Bhaskara Rao Bollineni (68.8%)
Soptex Developements Limited (1.45%)
20.11%
Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ
QoQ Growth in quarter ended Mar 2026 is -300.00% vs 1,330.77% in Dec 2025
QoQ Growth in quarter ended Mar 2026 is -717.65% vs 347.92% in Dec 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 4.83% vs -28.08% in Sep 2024
Growth in half year ended Sep 2025 is 8.71% vs -54.56% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is 1,175.71% vs -93.86% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 346.06% vs -117.61% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is 149.01% vs -120.09% in Mar 2025
YoY Growth in year ended Mar 2026 is 53.32% vs -144.79% in Mar 2025






